国药一致 (000028.sz)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

财务分析(报告期)(国药一致)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年一季报2023年年报2023年三季报2023年中报2023年一季报2022年年报2022年三季报2022年中报2022年一季报
主要指标:
 营业收入(元) 19,090,480,767.9075,477,484,620.3156,585,864,462.4338,387,531,548.0218,686,817,786.5073,443,136,988.1454,616,766,496.7236,128,910,049.9817,150,856,946.54
 营业利润(元) 544,001,136.482,467,425,159.541,822,923,220.301,295,113,233.31576,353,112.102,306,068,620.281,564,241,232.651,032,390,918.19375,078,310.57
 利润总额(元) 550,249,302.132,473,226,544.951,820,452,853.951,291,654,341.53578,487,139.582,311,070,116.471,569,397,344.061,034,555,447.84376,766,097.99
 净利润(元) 446,123,063.021,958,487,100.701,450,194,883.181,029,405,515.14460,830,788.651,771,737,990.911,219,948,643.14794,769,092.77294,771,604.63
 归属于母公司股东的净利润(元) 388,770,710.071,599,255,755.531,189,663,637.63830,251,088.20362,205,346.221,486,707,652.271,047,644,112.13674,215,912.93252,361,872.69
盈利能力:
 销售毛利率(%) 10.8611.9911.5611.5911.4212.1511.4911.6011.21
 销售净利率(%) 2.342.592.562.682.472.412.232.201.72
 净资产收益率(%) 2.279.547.285.202.29----
 总资产报酬率ROA(%) 1.205.943.962.851.34----
 投入资本回报率ROIC(%) 1.305.834.293.051.375.844.032.630.98
营运能力:
 存货周转率(次) 2.028.405.974.131.98----
 应收账款周转率(次) 0.904.732.641.870.99----
 总资产周转率(次) 0.381.671.150.800.40----
偿债能力:
 资产负债率(%) 58.4355.9059.6659.7258.4754.3760.0859.6959.15
 股东权益比率(%) 34.5536.6133.4533.3134.4337.8433.1133.3833.84
 已获利息倍数(倍) 13.0713.0915.6718.5114.7213.1911.2610.307.30
 流动比率 1.441.491.411.411.431.511.401.401.40
 速动比率 1.111.121.081.061.051.071.041.041.02
发展能力:
 营业收入增长率(%) 2.162.773.616.258.967.448.788.946.86
 营业利润增长率(%) -5.617.0016.5425.4553.6618.11-1.81-9.21-20.42
 税后利润增长率(%) 7.337.5713.5623.1443.5311.24-2.47-9.07-23.25
 净资产增长率(%) 7.987.998.008.298.648.057.066.946.30
 总资产增长率(%) 7.6011.636.908.516.78-0.395.814.024.24

前瞻产业研究院